Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:15 PM
Ignite Modification Date:
2026-03-26 @ 3:15 PM
NCT ID:
NCT07336368
Eligibility Criteria:
Inclusion Criteria:
* Adults (≥18 years) with keloids or hypertrophic scars already scheduled to receive intralesional triamcinolone (TAC) as part of routine care.
* At least one keloid or hypertrophic scar with two comparable regions (≥2 cm each) suitable for split-treatment.
* Able to provide informed consent and complete pain assessments in English.
Exclusion Criteria:
* Keloid or hypertrophic scar located on the face (except earlobes), excluded for cosmetic reasons.
* Prior treatment to the study-selected keloid/hypertrophic scar based on self-report.
* Inability to complete study assessments due to cognitive or language barriers.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07336368
Study Brief:
Protocol Section:
NCT07336368